Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
Am J Clin Nutr. 2012 Dec;96(6):1437-46. doi: 10.3945/ajcn.112.044263. Epub 2012 Nov 7.
Multiple micronutrients (vitamin B complex and vitamins C and E) were effective at reducing infectious disease morbidity, HIV disease progression, and poor pregnancy outcomes in HIV-infected women.
The objective was to evaluate whether direct supplementation of these micronutrients to HIV-exposed infants reduces mortality and morbidity.
Infants born to HIV-infected women from Dar es Salaam, Tanzania, were randomly assigned to receive daily oral supplementation of multiple multivitamins (vitamin B complex and vitamins C and E) or placebo from age 6 wk for 24 mo. All-cause mortality, hospitalizations, and unscheduled clinic visits were recorded. Morbidities were recorded during monthly follow-up visits. All mothers received multiple micronutrients throughout the study.
A total of 1193 infants were randomly assigned to receive micronutrients and 1194 to receive placebo. There were 138 child deaths in the multivitamin group and 124 deaths in the placebo group (HR: 1.13; 95% CI: 0.88, 1.44; P = 0.33). Hospitalizations (RR: 0.83; 95% CI: 0.62, 1.13; P = 0.23), unscheduled clinic visits (RR: 0.97; 95% CI: 0.85, 1.10; P = 0.59), and maternal reports of diarrhea (RR: 0.97; 0.87, 1.10; P = 0.64) were not significantly different between the 2 groups. Fever (P = 0.02) and vomiting (P = 0.007) were significantly lower in the multivitamin group. Among 429 children whose mothers received antiretroviral (ARV) therapy, multivitamin use had no effect on mortality but was associated with a significant reduction in hospitalizations (P = 0.035), episodes of fever (P = 0.005), and episodes of fever and cough (P = 0.019).
In the setting of maternal micronutrient supplementation, supplementation of HIV-exposed infants with vitamin B and vitamins C and E does not reduce mortality. Studies of nutrition supplementation in ARV-exposed infants may be warranted.
多种微量营养素(维生素 B 复合物以及维生素 C 和 E)在降低感染性疾病发病率、HIV 疾病进展和改善 HIV 感染妇女的不良妊娠结局方面具有显著效果。
本研究旨在评估直接向 HIV 暴露婴儿补充这些微量营养素是否能够降低死亡率和发病率。
来自坦桑尼亚达累斯萨拉姆的 HIV 感染女性所生婴儿在 6 周龄时被随机分配接受每日口服补充多种复合维生素(维生素 B 复合物以及维生素 C 和 E)或安慰剂,疗程 24 个月。记录所有原因死亡率、住院率和非计划就诊率。每月随访时记录发病率。所有母亲在整个研究期间均接受多种微量营养素补充。
共有 1193 名婴儿被随机分配接受微量营养素补充,1194 名婴儿接受安慰剂。在复合维生素组中有 138 名儿童死亡,在安慰剂组中有 124 名儿童死亡(HR:1.13;95%CI:0.88,1.44;P = 0.33)。住院率(RR:0.83;95%CI:0.62,1.13;P = 0.23)、非计划就诊率(RR:0.97;95%CI:0.85,1.10;P = 0.59)和母亲报告的腹泻率(RR:0.97;0.87,1.10;P = 0.64)在两组之间无显著差异。发热(P = 0.02)和呕吐(P = 0.007)在复合维生素组中显著较低。在 429 名接受抗逆转录病毒(ARV)治疗的母亲中,复合维生素的使用对死亡率没有影响,但与住院率显著降低相关(P = 0.035),发热发作(P = 0.005)和发热伴咳嗽发作(P = 0.019)的发生率降低相关。
在母亲补充微量营养素的情况下,向 HIV 暴露婴儿补充维生素 B 和维生素 C 和 E 并不能降低死亡率。可能需要进行针对接受 ARV 暴露的婴儿的营养补充研究。